Trials / Completed
CompletedNCT04220099
Electroencephalogram (EEG) and Electroconvulsive Therapy(ECT) Response in Schizophrenia
Pretreatment Electroencephalogram (EEG) May Predict Electroconvulsive Therapy(ECT) Effect in Schizophrenia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to find quantitative Electroencephalogram(qEEG) biomarkers to predict Electroconvulsive Therapy(ECT) Response in Schizophrenia
Detailed description
The purpose of this proposal is to explore quantitative Electroencephalogram(qEEG) biomarkers that would predict Electroconvulsive Therapy(ECT) Response in Schizophrenia (SZD). The investigators will recruit 30 SZD patients who are preparing for ECT treatment and assesse psychotic symptoms using Positive and Negative symptom scale(PANSS) before and after 8-sessions clinical course of ECT treatment. These patients needed ECT treatment are assessed by clinicians according to American Psychiatric Association(APA) guidelines. Meanwhile resting EEG will be recorded for 10 minutes before the first episode of ECT treatment. Decrease of PANSS scores will be calculated after the last session of ECT treatment to distinguish responder/non-responder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Electroconvulsive therapy(ECT) | Patients recieve 8-sessions ECT treatments and those kinds of drugs they take since they were recruited remain unchanged during this study. |
Timeline
- Start date
- 2020-01-07
- Primary completion
- 2020-06-05
- Completion
- 2020-07-04
- First posted
- 2020-01-07
- Last updated
- 2020-07-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04220099. Inclusion in this directory is not an endorsement.